IMPACT BIOMEDICAL INC. Contracts & Agreements

Executive Employment Agreement, dated as of October 3, 2024, between Impact Biomedical Inc. and Frank D. Heuszel (Filed With SEC on October 8, 2024)

Underwriting Agreement dated September 16, 2024 between the Company and Revere Securities LLC (Filed With SEC on September 17, 2024)

Form of Underwriting Agreement between the Company and Revere Securities, LLC and Dawson James Securities Inc (Filed With SEC on August 20, 2024)

Form of Underwriter Warrant (Filed With SEC on August 20, 2024)

Amendment to Promissory Note effective January 18, 2024 between Impact BioMedical Inc. and DSS, Inc (Filed With SEC on August 20, 2024)

Form of Underwriting Agreement between the Company and Revere Securities, LLC (Filed With SEC on June 11, 2024)

Form of Underwriter Warrant (Filed With SEC on June 11, 2024)

Amendment to Promissory Note effective January 18, 2024 between Impact BioMedical Inc. and DSS, Inc (Filed With SEC on June 11, 2024)

Form of Underwriting Agreement between the Company and Aegis Capital Corp (Filed With SEC on February 28, 2024)

Form of Underwriter Warrant (Filed With SEC on February 28, 2024)

Amendment to Promissory Note effective January 18, 2024 between Impact BioMedical Inc. and DSS, Inc (Filed With SEC on February 28, 2024)

Amendment to Promissory Note effective January 18, 2024 between Impact BioMedical Inc. and DSS, Inc (Filed With SEC on January 22, 2024)

Form of Underwriting Agreement between the Company and Aegis Capital Corp (Filed With SEC on November 21, 2023)

Form of Underwriter Warrant (Filed With SEC on November 21, 2023)

Share Exchange Agreement between Impact BioMedical Inc. and DSS BioHealth Security, Inc (Filed With SEC on November 21, 2023)

Share Exchange Agreement between Impact BioMedical Inc. and DSS BioHealth Security, Inc., dated October 31, 2023 (Filed With SEC on November 6, 2023)

Form of Underwriting Agreement between the Company and Aegis Capital Corp (Filed With SEC on November 1, 2023)

Form of Underwriter Warrant (Filed With SEC on November 1, 2023)

Share Exchange Agreement between Impact BioMedical Inc. and DSS BioHealth Security, Inc (Filed With SEC on November 1, 2023)

Share Exchange Agreement dated as of April 27, 2020, among Document Security Systems, Inc., DSS BioHealth Security, Inc., Singapore eDevelopment Limited and Global BioMedical Pte... (Filed With SEC on October 17, 2023)

Subscription Agreement dated December 19, 2020, between the Company and BioMed Technologies Asia Pacific Holdings Limited (Filed With SEC on October 17, 2023)

Promissory Note with Dustin Michael Crum dated February 21, 2021 (Filed With SEC on October 17, 2023)

Stock Purchase Agreement dated March 15, 2021 between the Company and Vivacitas Oncology Inc (Filed With SEC on October 17, 2023)

Convertible Promissory Note dated May 14, 2021 (Filed With SEC on October 17, 2023)

Revolving Promissory Note dated December 31, 2020 (Filed With SEC on October 17, 2023)

Royalty Agreement by and between Global BioLife Inc. and Chemia Corporation, dated August 15, 2018 (Filed With SEC on October 17, 2023)

Addendum to Royalty Agreement by and between Global BioLife Inc. and Chemia Corporation, dated November 27, 2018 (Filed With SEC on October 17, 2023)

Distribution Agreement by and between BioMed Technologies Asia Pacific Holdings Limited and Impact BioMedical Inc., dated December 9, 2020 (Filed With SEC on October 17, 2023)

Global BioLife, Inc. Stockholders Agreement among Global BioLife, Inc., Global BioMedical, Inc., Holista Colltech Limited, and GRDG Sciences, LLC, dated April 26, 2017 (Filed With SEC on October 17, 2023)

Amendment No. 1 to Global BioLife, Inc. Stockholders Agreement among Global BioLife, Inc., Global BioMedical, Inc., Holista Colltech Limited, and GRDG Sciences, LLC, dated May 22,... (Filed With SEC on October 17, 2023)

Amendment No. 2 to Global BioLife, Inc. Stockholders Agreement among Global BioLife, Inc., Global BioMedical, Inc., Holista Colltech Limited, and GRDG Sciences, LLC, dated August... (Filed With SEC on October 17, 2023)

Impact BioLife Science, Inc. Stockholders Agreement among Impact BioLife Science, Inc., Impact BioMedical Inc. and GRDG Sciences, LLC, dated December 11, 2020 (Filed With SEC on October 17, 2023)

Licensing Proceeds Distribution Agreement with GRDG Sciences, LLC dated May 16, 2022 (Filed With SEC on October 17, 2023)

Amendment No. 1 to Revolving Promissory Note dated December 31, 2021 (Filed With SEC on October 17, 2023)

Amendment No. 2 to Revolving Promissory Note dated March 31, 2022 (Filed With SEC on October 17, 2023)

License Agreement with ProPhase Labs, Inc. dated March 17, 2022 (Filed With SEC on October 17, 2023)

License Agreement with ProPhase Labs, Inc. dated July 18, 2022 (Filed With SEC on October 17, 2023)

Licensing Proceeds Distribution Agreement with GRDG Sciences, LLC dated February 15, 2022 (Filed With SEC on October 17, 2023)

Promissory Note with Dustin Michael Crum dated February 21, 2021 (Filed With SEC on August 24, 2022)

Licensing Proceeds Distribution Agreement with GRDG Sciences, LLC dated May 16, 2022 (Filed With SEC on August 24, 2022)

Subscription Agreement dated December 19, 2020, between the Company and BioMed Technologies Asia Pacific Holdings Limited (Filed With SEC on August 2, 2022)

Revolving Promissory Note dated December 31, 2020 (Filed With SEC on August 2, 2022)

Royalty Agreement by and between Global BioLife Inc. and Chemia Corporation, dated August 15, 2018 (Filed With SEC on August 2, 2022)

Addendum to Royalty Agreement by and between Global BioLife Inc. and Chemia Corporation, dated November 27, 2018 (Filed With SEC on August 2, 2022)

Distribution Agreement by and between BioMed Technologies Asia Pacific Holdings Limited and Impact BioMedical, Inc., dated December 9, 2020 (Filed With SEC on August 2, 2022)

Global BioLife, Inc. Stockholders Agreement among Global BioLife, Inc., Global BioMedical, Inc., Holista Colltech Limited, and GRDG Sciences, LLC, dated April 26, 2017 (Filed With SEC on August 2, 2022)

Amendment No. 1 to Global BioLife, Inc. Stockholders Agreement among Global BioLife, Inc., Global BioMedical, Inc., Holista Colltech Limited, and GRDG Sciences, LLC, dated May 22,... (Filed With SEC on August 2, 2022)

AMENDMENTNO. 2 TO GLOBALBIOLIFE, INC. STOCKHOLDERS’AGREEMENT (Filed With SEC on August 2, 2022)

Impact BioLife Science, Inc. Stockholders Agreement among Impact BioLife Science, Inc., Impact BioMedical, Inc. and GRDG Sciences, LLC, dated December 11, 2020 (Filed With SEC on August 2, 2022)

Amendment No. 1 to Revolving Promissory Note dated December 31, 2021 (Filed With SEC on August 2, 2022)

Amendment No. 2 to Revolving Promissory Note dated March 31, 2022 (Filed With SEC on August 2, 2022)

License Agreement with ProPhase Labs, Inc. dated March 17, 2022 (Filed With SEC on August 2, 2022)

License Agreement with ProPhase Labs, Inc. dated July 18, 2022 (Filed With SEC on August 2, 2022)

Licensing Proceeds Distribution Agreement with GRDG Sciences, LLC dated February 15, 2022 (Filed With SEC on August 2, 2022)

Stock Purchase Agreement dated March 15, 2021 between the Company and Vivacitas Oncology Inc (Filed With SEC on June 24, 2022)

Convertible Promissory Note dated May 14, 2021 (Filed With SEC on June 24, 2022)

Amendment No. 2 to Global BioLife, Inc. Stockholders Agreement among Global BioLife, Inc., Global BioMedical, Inc., Holista Colltech Limited, and GRDG Sciences, LLC, dated August... (Filed With SEC on June 24, 2022)

Impact BioLife Science, Inc. Stockholders Agreement among Impact BioLife Science, Inc., Impact BioMedical, Inc. and GRDG Sciences, LLC, dated December 11, 2020 (Filed With SEC on June 24, 2022)

Share Exchange Agreement dated as of April 27, 2020, among Document Security Systems, Inc., DSS BioHealth Security, Inc., Singapore eDevelopment Limited and Global BioMedical Pte... (Filed With SEC on September 29, 2021)

Category

Industry

Companies

Contracts

IMPACT BIOMEDICAL INC. Contracts & Agreements